RAM
BIOR

Riggs Asset Management’s Biora Therapeutics, Inc. Common Stock BIOR Stock Holding History

Riggs Asset Management’s Portfolio BIOR Stock Details BIOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-40
Closed -$201 – 702
2024
Q3 		$201 Hold
40
– – ﹤0.01% 621
2024
Q2 		$264 Hold
40
– – ﹤0.01% 623
2024
Q1 		$440 Buy
40
+10
+33% +$108 ﹤0.01% 550
2023
Q4 		$405 Hold
30
– – ﹤0.01% 393
2023
Q3 		$651 Buy
30
+10
+50% +$321 ﹤0.01% 381
2023
Q2 		$770 Buy
20
+18
+900% +$635 ﹤0.01% 354
2023
Q1 		$61 Hold
2
– – ﹤0.01% 364
2022
Q4 		$72 Hold
2
– – ﹤0.01% 325
2022
Q3 		$0 Buy
+2
New +$360 ﹤0.01% 359

Riggs Asset Management's BIOR Position: Q4 2024 in Review

Riggs Asset Management sold out of Biora Therapeutics, Inc. Common Stock (BIOR) in Q4 2024, closing a stake of 40 shares — an estimated $201 sold.

Riggs Asset Management first reported a position in BIOR in Q3 2022 and held it in 9 quarters. The position peaked at $770 in Q2 2023. 0 funds tracked by Wall St. Rank hold BIOR as of Q4 2024.

  • Riggs Asset Management reported no remaining Biora Therapeutics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Riggs Asset Management sold 40 Biora Therapeutics, Inc. Common Stock shares in Q4 2024, an estimated $201.
  • Riggs Asset Management first reported a position in Biora Therapeutics, Inc. Common Stock in Q3 2022 and held it in 9 quarters.
  • Riggs Asset Management's Biora Therapeutics, Inc. Common Stock position peaked at $770 in Q2 2023.
  • 0 funds tracked by Wall St. Rank held Biora Therapeutics, Inc. Common Stock as of Q4 2024.

Based on Riggs Asset Management's 13F filing for Q4 2024, filed 24 Jan 2025.